Tag

phase-2

preliminary esophageal pneumonitis phase-2

Tetrandrine trial will test prevention of lung injury during esophageal chemoradiotherapy

A randomized phase II trial will test whether intravenous tetrandrine reduces grade 2 or higher lung injury from 25% to 10%.

RadOncToday · 28 Jul 2026 ·1 min read

trial nsclc immuno-rt phase-2

Durvalumab with radiotherapy achieved 39% two-year PFS in cCRT-ineligible NSCLC

Concurrent and consolidative durvalumab with definitive radiotherapy produced 39% two-year progression-free survival in patients ineligible for concurrent chemoradiotherapy.

RadOncToday · 17 Jul 2026 ·1 min read